Bulletin
Investor Alert

Centene Corp.

NYS: CNC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2020, 7:45 p.m.

CNC
/zigman2/quotes/208900023/composite

$

65.97

Change

+0.28 +0.43%

Volume

Volume 77,969

Quotes are delayed by 20 min

/zigman2/quotes/208900023/composite

Previous close

$ 64.49

$ 65.69

Change

+1.20 +1.86%

Day low

Day high

$62.37

$65.74

Open

52 week low

52 week high

$41.62

$74.70

Open

Jesse N. Hunter

Jesse N. Hunter is on the board of Health Net LLC and RxAdvance Corp. and Chief Strategy Office, EVP-Mergers & Acquisition at Centene Corp.

Transactions

Date Shares Transaction Value
02/04/2020 29,728   Derivative/Non-derivative trans. at $62.88 per share. 1,869,297
02/04/2020 24,360   Award at $28.13 per share. 685,246
12/19/2019 1,074   Derivative/Non-derivative trans. at $60.35 per share. 64,816
12/13/2019 4,177   Derivative/Non-derivative trans. at $58.52 per share. 244,439
12/12/2019 2,507   Derivative/Non-derivative trans. at $58.64 per share. 147,011
12/11/2019 1,910   Derivative/Non-derivative trans. at $59.62 per share. 113,875
12/10/2019 50,000   Award at $59.17 per share. 2,958,500
12/04/2019 2,500   Gift at $0 per share. 0
12/04/2019 575   Gift at $0 per share. 0
11/18/2019 20,000   Disposition at $60 per share. 1,200,000
02/05/2019 26,724   Derivative/Non-derivative trans. at $64.99 per share. 1,736,793
02/05/2019 19,600   Award at $28.4 per share. 556,640
12/19/2018 9,000   Award at $120.09 per share. 1,080,810
12/18/2018 10,000   Disposition at $121.26 per share. 1,212,600
12/15/2018 3,017   Derivative/Non-derivative trans. at $127.53 per share. 384,759
12/13/2018 2,112   Derivative/Non-derivative trans. at $134.29 per share. 283,621
12/12/2018 1,268   Derivative/Non-derivative trans. at $132.83 per share. 168,429
12/11/2018 16,000   Award at $132.46 per share. 2,119,360
08/29/2018 1,850   Gift at $0 per share. 0
07/26/2018 5,000   Disposition at $131.9 per share. 659,500
04/26/2018 5,000   Disposition at $108.34 per share. 541,700
04/04/2018 3,975   Derivative/Non-derivative trans. at $106.21 per share. 422,185
04/04/2018 8,000   Derivative/Non-derivative trans. at $8.42 per share. 67,360
12/27/2017 2,500   Gift at $0 per share. 0
12/19/2017 10,000   Disposition at $98.73 per share. 987,300
12/15/2017 3,197   Derivative/Non-derivative trans. at $99.02 per share. 316,567
12/13/2017 2,238   Derivative/Non-derivative trans. at $100.86 per share. 225,725
12/12/2017 21,000   Award at $99.7 per share. 2,093,700
12/11/2017 998   Derivative/Non-derivative trans. at $101.34 per share. 101,138
12/11/2017 12,000   Derivative/Non-derivative trans. at $8.42 per share. 101,040
12/09/2017 9,590   Derivative/Non-derivative trans. at $101.34 per share. 971,851
05/01/2017 5,000   Disposition at $74.4 per share. 372,000
05/01/2017 325   Gift at $0 per share. 0
02/17/2017 1,500   Gift at $0 per share. 0
02/13/2017 5,000   Disposition at $69.54 per share. 347,700
12/15/2016 3,197   Derivative/Non-derivative trans. at $56.14 per share. 179,480
12/13/2016 35,000   Award at $56.26 per share. 1,969,100
12/10/2016 7,994   Derivative/Non-derivative trans. at $56.8 per share. 454,060
12/09/2016 9,590   Derivative/Non-derivative trans. at $56.94 per share. 546,055
11/07/2016 5,000   Disposition at $65 per share. 325,000
06/24/2016 7,596   Derivative/Non-derivative trans. at $69.84 per share. 530,505
06/24/2016 24,000   Derivative/Non-derivative trans. at $12.6 per share. 302,400
04/28/2016 10,000   Disposition at $65.17 per share. 651,700
02/09/2016 3,390   Derivative/Non-derivative trans. at $53.72 per share. 182,111
01/04/2016 7,500   Disposition at $65 per share. 487,500
12/15/2015 40,000   Award at $56.8 per share. 2,272,000
12/11/2015 7,034   Derivative/Non-derivative trans. at $57.47 per share. 404,244
12/10/2015 7,992   Derivative/Non-derivative trans. at $57.52 per share. 459,700
12/09/2015 4,795   Derivative/Non-derivative trans. at $57.4 per share. 275,233

Officers and Executives

Mr. Michael F. Neidorff
Chairman, President & Chief Executive Officer
Ms. Brandy Burkhalter
Chief Operating Officer & Executive Vice President
Mr. Jeffrey A. Schwaneke
Chief Financial Officer, Treasurer & Executive VP
Dr. Ken Yamaguchi
Chief Medical Officer & Executive Vice President
Dr. Mary V. Mason
Chief Medial Officer & Senior Vice President
Mr. Mark J. Brooks
Chief Information Officer & Executive VP
Mr. Kenneth A. Burdick
Executive Vice President-Products & Markets
Mr. David P. Thomas
Executive Vice President-Markets
Ms. Kathleen Hodson
Vice President-Staff Business Operations
Dr. Robert C. Packman
Senior Vice President-Medical Affairs
Ms. Holly Benson
Executive Vice President
Mr. Jesse N. Hunter
Chief Strategy Office, EVP-Mergers & Acquisition
Mr. Kevin J. Counihan
Senior Vice President-Products
Mr. Anand Shukla
SVP-Commercial Solutions
Mr. Arvan See Wing Chan
Regional Vice President & Corporate Operations
Mr. Brent Davis Layton
Chief Business Development Officer & EVP
Mr. Claudio Abreu
Executive Vice President
Mr. Steven J. Sell
CEO & Plan President-CA Market
Mr. Patrick J. Frawley
Senior Vice President-Social Responsibility
Mr. Matthew Snyder
SVP-Internal Audit, Compliance & Risk Management
Ms. Lori J. Robinson
Director
Mr. William L. Trubeck
Director
Mr. H. James Dallas
Director
Mr. Christopher R. Isaak
Chief Accounting Officer, Senior VP & Controller
Ms. Jennifer Gilligan
Senior Vice President-Investor Relations
Mr. Chris Koster
Secretary, Senior Vice President & General Counsel
Mr. David L. Steward
Independent Director
Mr. Robert K. Ditmore
Independent Director
Mr. Tommy George Thompson
Independent Director
Mr. Orlando Lozano Ayala
Independent Director
Mr. Richard A. Gephardt
Independent Director
Mr. John R. Roberts
Independent Director
Mr. Frederick H. Eppinger
Independent Director
Ms. Jessica L. Blume
Independent Director
Link to MarketWatch's Slice.